| Trade Date |
Insider |
Title |
Buy or Sell |
Quantity |
Security Type |
Price |
Proceeds |
Transaction Conviction |
Position Quantity |
Position Value |
Positon Conviction |
SEC Link |
Nature of Ownership |
2020-04-06 | Patrick Miles | CEO | Buy | 28,268 | Common Stock | $3.93 | -$111,093.24 | 4.41 [ Very High ] | 4,179,189 | $16,424,212.77 | 652.50 [Very High] | Form 4 | - | 2020-04-06 | Kelli Mari Howell | EVP, Clinical Strategies | Buy | 11,136 | Common Stock | $3.93 | -$43,764.48 | 1.74 [ High ] | 402,015 | $1,579,918.95 | 62.77 [High] | Form 4 | - | 2020-04-06 | Craig E Hunsaker | EVP, People/Culture & GC | Buy | 17,988 | Common Stock | $3.93 | -$70,692.84 | 2.81 [ Very High ] | 880,936 | $3,462,078.48 | 137.54 [Very High] | Form 4 | - | 2020-04-06 | Jeffrey G. Black | EVP & CFO | Buy | 5,996 | Common Stock | $3.93 | -$23,564.28 | 0.94 [ High ] | 511,295 | $2,009,389.35 | 79.83 [High] | Form 4 | - | 2020-04-06 | Brian Snider | EVP, Strat. Mktg. & Prod. Dev. | Buy | 5,482 | Common Stock | $3.93 | -$21,544.26 | 0.86 [ High ] | 498,489 | $1,959,061.77 | 77.83 [High] | Form 4 | - | 2020-04-06 | David Sponsel | EVP, Sales | Buy | 2,398 | Common Stock | $3.93 | -$9,424.14 | 0.37 [ Average ] | 445,417 | $1,750,488.81 | 69.54 [High] | Form 4 | - | 2020-04-22 | Patrick Miles | CEO | Buy | 875,660 | Common Stock | $0.00 | $0.00 | - | 5,054,849 | $0.00 | 789.22 [Very High] | Form 4 | - | 2020-04-22 | Brian Snider | EVP, Strat. Mktg. & Prod. Dev. | Buy | 142,228 | Common Stock | $0.00 | $0.00 | - | 640,717 | $0.00 | 100.04 [Very High] | Form 4 | - | 2020-04-22 | David Sponsel | EVP, Sales | Buy | 216,422 | Common Stock | $0.00 | $0.00 | - | 661,839 | $0.00 | 103.33 [Very High] | Form 4 | - | 2020-04-22 | Jeffrey G. Black | EVP & CFO | Buy | 179,178 | Common Stock | $0.00 | $0.00 | - | 690,473 | $0.00 | 107.80 [Very High] | Form 4 | - | 2020-04-22 | Craig E Hunsaker | EVP, People/Culture & GC | Buy | 167,156 | Common Stock | $0.00 | $0.00 | - | 1,048,092 | $0.00 | 163.64 [Very High] | Form 4 | - | 2020-04-22 | Kelli Mari Howell | EVP, Clinical Strategies | Buy | 98,534 | Common Stock | $0.00 | $0.00 | - | 500,549 | $0.00 | 78.15 [High] | Form 4 | - | 2020-05-14 | Jeffrey G. Black | EVP & CFO | Sell | 23,774 | Common Stock | $4.06 | $96,522.44 | 3.71 [ Very High ] | 666,699 | $2,706,797.94 | 104.09 [Very High] | Form 4 | - | 2020-06-16 | Tullis James L L | - | Sell | 38,000 | Common Stock | $5.15 | $195,700.00 | - | 715,828 | $3,686,514.20 | - | Form 4 | By Tullis Growth Fund, L.P. | 2020-06-17 | Tullis James L L | - | Buy | 22,146 | Common Stock | $0.00 | $0.00 | - | 127,734 | $0.00 | - | Form 4 | - | 2020-06-17 | Karen K Mcginnis | - | Buy | 23,784 | Common Stock | $0.00 | $0.00 | - | 40,439 | $0.00 | - | Form 4 | - | 2020-06-17 | Woods Ward W Jr | - | Buy | 24,049 | Common Stock | $0.00 | $0.00 | - | 83,738 | $0.00 | - | Form 4 | - | 2020-06-17 | Jeffrey P Rydin | - | Buy | 21,142 | Common Stock | $0.00 | $0.00 | - | 414,888 | $0.00 | - | Form 4 | - | 2020-06-17 | David R Pelizzon | - | Buy | 21,142 | Common Stock | $0.00 | $0.00 | - | 137,139 | $0.00 | - | Form 4 | - | 2020-06-17 | Donald Allen Williams | - | Buy | 26,956 | Common Stock | $0.00 | $0.00 | - | 124,507 | $0.00 | - | Form 4 | - | 2020-06-17 | Evan Bakst | - | Buy | 21,142 | Common Stock | $0.00 | $0.00 | - | 766,140 | $0.00 | - | Form 4 | - | 2020-06-17 | Quentin S. Blackford | - | Buy | 28,013 | Common Stock | $0.00 | $0.00 | - | 530,180 | $0.00 | - | Form 4 | - | 2020-06-17 | Jason Hochberg | - | Buy | 21,142 | Common Stock | $0.00 | $0.00 | - | 64,154 | $0.00 | - | Form 4 | - | 2020-06-17 | David H Mowry | - | Buy | 24,313 | Common Stock | $0.00 | $0.00 | - | 81,830 | $0.00 | - | Form 4 | - | 2020-08-04 | Jeffrey G. Black | EVP & CFO | Sell | 8,929 | Common Stock | $5.03 | $44,912.87 | 1.39 [ High ] | 657,770 | $3,308,583.10 | 102.70 [Very High] | Form 4 | - | 2020-08-11 | Jeffrey G. Black | EVP & CFO | Sell | 5,000 | Common Stock | $6.42 | $32,100.00 | 0.78 [ High ] | 652,770 | $4,190,783.40 | 101.51 [Very High] | Form 4 | - | 2020-10-08 | Craig E Hunsaker | EVP, People/Culture & GC | Sell | 32,000 | Common Stock | $8.25 | $264,000.00 | 4.98 [ Very High ] | 1,016,092 | $8,382,759.00 | 158.02 [Very High] | Form 4 | - | 2020-10-08 | Craig E Hunsaker | EVP, People/Culture & GC | Sell | 30,731 | Common Stock | $9.00 | $276,579.00 | 4.78 [ Very High ] | 985,361 | $8,868,249.00 | 153.24 [Very High] | Form 4 | - | 2020-10-12 | David Sponsel | EVP, Sales | Sell | 89,999 | Common Stock | $9.47 | $852,290.53 | 14.00 [ Very High ] | 571,840 | $5,415,324.80 | 88.93 [Very High] | Form 4 | - | 2020-11-16 | Scott Lish | SVP, Development | Sell | 2,162 | Common Stock | $9.82 | $21,230.84 | 0.28 [ Low ] | 293,247 | $2,879,685.54 | 37.39 [High] | Form 4 | - | 2020-12-01 | Tullis James L L | - | Sell | 600,000 | Common Stock | $0.00 | $0.00 | - | 1,143,803 | $0.00 | 145.85 [Very High] | Form 4 | By Tullis Dickerson Capital Focus III, LP | 2020-12-01 | Tullis James L L | - | Buy | 116,355 | Common Stock | $0.00 | $0.00 | - | 116,355 | $0.00 | 14.84 [Average] | Form 4 | By Tullis-Dickerson Partners III, LLC | 2020-12-18 | David R Pelizzon | - | Buy | 1,350,135 | Common Stock | $11.11 | -$14,999,999.85 | 172.16 [ Very High ] | 2,437,092 | $27,076,092.12 | 310.75 [Very High] | Form 4 | By Squadron Capital LLC | 2020-12-18 | Tullis James L L | - | Sell | 29 | Common Stock | $0.00 | $0.00 | - | 127,705 | $0.00 | 16.28 [High] | Form 4 | - | 2021-01-21 | Tullis James L L | - | Sell | 400,000 | Common Stock | $0.00 | $0.00 | - | 315,828 | $0.00 | 40.27 [High] | Form 4 | By Tullis Growth Fund, L.P. | 2021-01-21 | Tullis James L L | - | Buy | 4,714 | Common Stock | $0.00 | $0.00 | - | 132,419 | $0.00 | 16.88 [High] | Form 4 | - | 2021-02-16 | Jeffrey G. Black | EVP & CFO | Sell | 25,000 | Common Stock | $16.28 | $407,000.00 | 3.19 [ Very High ] | 627,770 | $10,220,095.60 | 80.05 [Very High] | Form 4 | - | 2021-02-18 | Patrick Miles | CEO | Buy | 50,000 | Common Stock | $0.00 | $0.00 | - | 5,104,849 | $0.00 | 650.92 [Very High] | Form 4 | - | 2021-02-18 | Scott Lish | SVP, Development | Buy | 35,000 | Common Stock | $0.00 | $0.00 | - | 328,247 | $0.00 | 41.85 [High] | Form 4 | - | 2021-02-18 | Craig E Hunsaker | EVP, People/Culture & GC | Buy | 50,000 | Common Stock | $0.00 | $0.00 | - | 1,033,361 | $0.00 | 131.76 [Very High] | Form 4 | - | 2021-02-18 | David Sponsel | EVP, Sales | Sell | 40,000 | Common Stock | $0.00 | $0.00 | - | 612,756 | $0.00 | 78.13 [Very High] | Form 4 | - | 2021-02-18 | Kelli Mari Howell | EVP, Clinical Strategies | Buy | 20,000 | Common Stock | $0.00 | $0.00 | - | 523,941 | $0.00 | 66.81 [High] | Form 4 | - | 2021-02-18 | Brian Snider | EVP, Strat. Mktg. & Prod. Dev. | Buy | 20,000 | Common Stock | $0.00 | $0.00 | - | 666,226 | $0.00 | 84.95 [Very High] | Form 4 | - | 2021-02-23 | Tullis James L L | - | Buy | 18,337 | Common Stock | $3.50 | -$64,179.50 | 2.34 [ High ] | 150,756 | $527,646.00 | 19.22 [High] | Form 4 | - | 2021-02-23 | Tullis James L L | - | Sell | 3,887 | Common Stock | $16.51 | $64,174.37 | 0.50 [ Average ] | 146,869 | $2,424,807.19 | 18.73 [High] | Form 4 | - | 2021-02-23 | Tullis James L L | - | Buy | 320,325 | Common Stock | $3.50 | -$1,121,137.50 | 40.84 [ Very High ] | 636,153 | $2,226,535.50 | 81.12 [Very High] | Form 4 | By Tullis Growth Fund, L.P. | 2021-02-23 | Tullis James L L | - | Sell | 67,906 | Common Stock | $16.51 | $1,121,128.06 | 8.66 [ Very High ] | 568,247 | $9,381,757.97 | 72.46 [Very High] | Form 4 | By Tullis Growth Fund, L.P. | 2021-02-23 | Tullis James L L | - | Buy | 440,973 | Common Stock | $3.50 | -$1,543,405.50 | 56.23 [ Very High ] | 1,584,776 | $5,546,716.00 | 202.08 [Very High] | Form 4 | By Tullis Dickerson Capital Focus III, LP | 2021-02-23 | Tullis James L L | - | Sell | 93,483 | Common Stock | $16.51 | $1,543,404.33 | 11.92 [ Very High ] | 1,491,293 | $24,621,247.43 | 190.16 [Very High] | Form 4 | By Tullis Dickerson Capital Focus III, LP | 2021-02-23 | Tullis James L L | - | Sell | 600,000 | Common Stock | $0.00 | $0.00 | - | 891,293 | $0.00 | 113.65 [Very High] | Form 4 | By Tullis Dickerson Capital Focus III, LP | 2021-02-23 | Tullis James L L | - | Buy | 131,870 | Common Stock | $0.00 | $0.00 | - | 248,225 | $0.00 | 31.65 [High] | Form 4 | By Tullis-Dickerson Partners III, LLC | 2021-03-01 | David R Pelizzon | - | Buy | 8,100,810 | Common Stock | $11.11 | -$89,999,999.10 | 1,032.94 [ Very High ] | 11,395,045 | $126,598,949.95 | 1,452.99 [Very High] | Form 4 | By Squadron Capital LLC | 2021-03-01 | Scott Lish | SVP, Development | Sell | 18,842 | Common Stock | $16.54 | $311,646.68 | 2.40 [ High ] | 309,405 | $5,117,558.70 | 39.45 [High] | Form 4 | - | 2021-03-08 | David R Pelizzon | - | Buy | 4,003 | Common Stock | $15.50 | -$62,046.50 | 0.42 [ Average ] | 148,142 | $2,296,201.00 | 15.57 [High] | Form 4 | - | 2021-03-08 | David R Pelizzon | - | Buy | 695 | Common Stock | $15.93 | -$11,071.35 | 0.07 [ Very Low ] | 148,837 | $2,370,973.41 | 15.64 [High] | Form 4 | - | 2021-03-09 | Jeffrey G. Black | EVP & CFO | Sell | 7,000 | Common Stock | $16.69 | $116,830.00 | 0.74 [ Average ] | 620,770 | $10,360,651.30 | 65.24 [Very High] | Form 4 | - | 2021-03-09 | Tullis James L L | - | Sell | 22,500 | Common Stock | $16.24 | $365,400.00 | 2.36 [ High ] | 545,747 | $8,862,931.28 | 57.36 [High] | Form 4 | By Tullis Growth Fund, L.P. | 2021-03-10 | Jennifer N. Pritzker | - | Buy | 1,000 | Common Stock | $16.40 | -$16,400.00 | 0.11 [ Low ] | 30,200 | $495,280.00 | 3.17 [Low] | Form 4 | - | 2021-03-10 | Jennifer N. Pritzker | - | Buy | 1,000 | Common Stock | $16.42 | -$16,420.00 | 0.11 [ Low ] | 31,200 | $512,304.00 | 3.28 [Low] | Form 4 | - | 2021-03-10 | Jennifer N. Pritzker | - | Buy | 1,000 | Common Stock | $16.31 | -$16,310.00 | 0.11 [ Low ] | 32,200 | $525,182.00 | 3.38 [Low] | Form 4 | - | 2021-03-25 | Brian Snider | EVP, Strat. Mktg. & Prod. Dev. | Sell | 6,484 | Common Stock | $16.68 | $108,153.12 | 0.68 [ Average ] | 659,742 | $11,004,496.56 | 69.34 [Very High] | Form 4 | - | 2021-04-29 | Brian Snider | EVP, Strat. Mktg. & Prod. Dev. | Sell | 20,080 | Common Stock | $16.33 | $327,906.40 | 2.11 [ High ] | 639,662 | $10,445,680.46 | 67.23 [Very High] | Form 4 | - | 2021-04-29 | Kelli Mari Howell | EVP, Clinical Strategies | Sell | 11,474 | Common Stock | $16.33 | $187,370.42 | 1.21 [ High ] | 512,467 | $8,368,586.11 | 53.86 [High] | Form 4 | - | 2021-04-29 | Patrick Miles | CEO | Sell | 146,074 | Common Stock | $16.33 | $2,385,388.42 | 15.35 [ Very High ] | 4,958,775 | $80,976,795.75 | 521.15 [Very High] | Form 4 | - | 2021-04-26 | David Sponsel | EVP, Sales | Sell | 14,572 | Common Stock | $16.63 | $242,332.36 | 1.53 [ High ] | 598,184 | $9,947,799.92 | 62.87 [High] | Form 4 | - | 2021-04-19 | John Todd Koning | Chief Financial Officer | Buy | 40,000 | Common Stock | $0.00 | $0.00 | - | 190,000 | $0.00 | 19.97 [High] | Form 4 | - | 2021-04-19 | John Todd Koning | Chief Financial Officer | Buy | 150,000 | Common Stock | $0.00 | $0.00 | - | 150,000 | $0.00 | 15.76 [High] | Form 4 | - | 2021-04-29 | Craig E Hunsaker | EVP, People/Culture & GC | Sell | 22,381 | Common Stock | $16.33 | $365,481.73 | 2.35 [ High ] | 1,080,140 | $17,638,686.20 | 113.52 [Very High] | Form 4 | - | 2021-05-03 | David Sponsel | EVP, Sales | Buy | 17,187 | Common Stock | $3.86 | -$66,341.82 | 1.81 [ High ] | 615,371 | $2,375,332.06 | 64.67 [Very High] | Form 4 | - | 2021-05-03 | David Sponsel | EVP, Sales | Buy | 12,813 | Common Stock | $3.17 | -$40,617.21 | 1.35 [ High ] | 628,184 | $1,991,343.28 | 66.02 [Very High] | Form 4 | - | 2021-05-03 | David Sponsel | EVP, Sales | Sell | 30,000 | Common Stock | $15.97 | $479,100.00 | 3.15 [ Very High ] | 598,184 | $9,552,998.48 | 62.87 [High] | Form 4 | - | 2021-05-10 | David R Pelizzon | - | Buy | 120,000 | Common Stock | $15.25 | -$1,830,000.00 | 12.31 [ Very High ] | 268,837 | $4,099,764.25 | 27.58 [High] | Form 4 | - | 2021-05-10 | Jennifer N. Pritzker | - | Buy | 4,000 | Common Stock | $14.38 | -$57,520.00 | 0.41 [ Average ] | 36,200 | $520,556.00 | 3.71 [Low] | Form 4 | - | 2021-05-10 | Jennifer N. Pritzker | - | Buy | 1,000 | Common Stock | $14.50 | -$14,500.00 | 0.10 [ Low ] | 1,000 | $14,500.00 | 0.10 [Very Low] | Form 4 | See footnote | 2021-05-10 | Jennifer N. Pritzker | - | Buy | 1,000 | Common Stock | $14.50 | -$14,500.00 | 0.10 [ Low ] | 1,000 | $14,500.00 | 0.10 [Very Low] | Form 4 | See footnote | 2021-05-10 | Jennifer N. Pritzker | - | Buy | 1,000 | Common Stock | $14.50 | -$14,500.00 | 0.10 [ Low ] | 1,000 | $14,500.00 | 0.10 [Very Low] | Form 4 | See footnote | 2021-05-17 | Craig E Hunsaker | EVP, People/Culture & GC | Sell | 28,271 | Common Stock | $14.81 | $418,693.51 | 2.90 [ Very High ] | 1,051,869 | $15,578,179.89 | 107.92 [Very High] | Form 4 | - | 2021-05-17 | David Sponsel | EVP, Sales | Buy | 34,087 | Common Stock | $14.81 | -$504,828.47 | 3.50 [ Very High ] | 564,317 | $8,357,534.77 | 57.90 [High] | Form 4 | - | 2021-05-17 | Kelli Mari Howell | EVP, Clinical Strategies | Sell | 17,525 | Common Stock | $14.81 | $259,545.25 | 1.80 [ High ] | 497,449 | $7,367,219.69 | 51.04 [High] | Form 4 | - | 2021-05-17 | Brian Snider | EVP, Strat. Mktg. & Prod. Dev. | Sell | 21,982 | Common Stock | $14.81 | $325,553.42 | 2.26 [ High ] | 619,190 | $9,170,203.90 | 63.53 [High] | Form 4 | - | 2021-06-16 | L-5 Healthcare Partners, Llc | - | Buy | 400,000 | Common Stock | $3.50 | -$1,400,000.00 | 41.04 [ Very High ] | 8,336,508 | $29,177,778.00 | 855.32 [Very High] | Form 4 | - | 2021-06-16 | L-5 Healthcare Partners, Llc | - | Sell | 93,747 | Common Stock | $14.93 | $1,399,642.71 | 9.62 [ Very High ] | 8,242,761 | $123,064,421.73 | 845.71 [Very High] | Form 4 | - | 2021-06-16 | Karen K Mcginnis | - | Buy | 10,221 | Common Stock | $0.00 | $0.00 | - | 50,660 | $0.00 | 5.20 [Average] | Form 4 | - | 2021-06-16 | Woods Ward W Jr | - | Buy | 10,221 | Common Stock | $0.00 | $0.00 | - | 93,959 | $0.00 | 9.64 [Average] | Form 4 | - | 2021-06-16 | Tullis James L L | - | Buy | 10,221 | Common Stock | $0.00 | $0.00 | - | 157,090 | $0.00 | 16.12 [High] | Form 4 | - | 2021-06-16 | Jeffrey P Rydin | - | Buy | 10,221 | Common Stock | $0.00 | $0.00 | - | 425,109 | $0.00 | 43.62 [High] | Form 4 | - | 2021-06-16 | David R Pelizzon | - | Buy | 10,221 | Common Stock | $0.00 | $0.00 | - | 279,058 | $0.00 | 28.63 [High] | Form 4 | - | 2021-06-16 | Evan Bakst | - | Buy | 10,221 | Common Stock | $0.00 | $0.00 | - | 776,361 | $0.00 | 79.65 [Very High] | Form 4 | - | 2021-06-16 | Quentin S. Blackford | - | Buy | 10,221 | Common Stock | $0.00 | $0.00 | - | 524,151 | $0.00 | 53.78 [High] | Form 4 | - | 2021-06-16 | Jason Hochberg | - | Buy | 10,221 | Common Stock | $0.00 | $0.00 | - | 74,375 | $0.00 | 7.63 [Average] | Form 4 | - | 2021-06-16 | David H Mowry | - | Buy | 10,221 | Common Stock | $0.00 | $0.00 | - | 92,051 | $0.00 | 9.44 [Average] | Form 4 | - | 2021-06-16 | Donald Allen Williams | - | Buy | 10,221 | Common Stock | $0.00 | $0.00 | - | 134,728 | $0.00 | 13.82 [Average] | Form 4 | - | 2021-06-16 | David Sponsel | EVP, Sales | Sell | 10,000 | Common Stock | $14.78 | $147,800.00 | 1.03 [ High ] | 554,317 | $8,192,805.26 | 56.87 [High] | Form 4 | - | 2021-06-17 | Marie Meynadier | - | Buy | 10,205 | Common Stock | $0.00 | $0.00 | - | 10,205 | $0.00 | 1.05 [Very Low] | Form 4 | - | 2021-06-17 | Marie Meynadier | - | Buy | 20,467 | Common Stock | $0.00 | $0.00 | - | 30,672 | $0.00 | 3.15 [Low] | Form 4 | - | 2021-07-01 | Patrick Miles | CEO | Sell | 154,938 | Common Stock | $15.32 | $2,373,650.16 | 15.90 [ Very High ] | 4,803,837 | $73,594,782.84 | 492.87 [Very High] | Form 4 | - | 2021-07-01 | David Sponsel | EVP, Sales | Sell | 3,099 | Common Stock | $15.32 | $47,476.68 | 0.32 [ Average ] | 551,218 | $8,444,659.76 | 56.55 [High] | Form 4 | - | 2021-07-12 | Scott Lish | SVP, Development | Sell | 11,965 | Common Stock | $16.46 | $196,943.90 | 1.23 [ High ] | 298,402 | $4,911,696.92 | 30.62 [High] | Form 4 | - | 2021-08-03 | Scott Lish | SVP, Development | Sell | 10,000 | Common Stock | $14.24 | $142,400.00 | 1.00 [ High ] | 288,402 | $4,106,844.48 | 28.81 [High] | Form 4 | - | 2021-08-06 | Patrick Miles | CEO | Buy | 250,000 | Common Stock | $2.00 | -$500,000.00 | 24.97 [ Very High ] | 5,053,837 | $10,107,674.00 | 504.79 [Very High] | Form 4 | - | 2021-08-05 | Kelli Mari Howell | EVP, Clinical Strategies | Sell | 6,050 | Common Stock | $15.23 | $92,141.50 | 0.60 [ Average ] | 491,399 | $7,484,006.77 | 49.08 [High] | Form 4 | - | 2021-08-05 | Brian Snider | EVP, Strat. Mktg. & Prod. Dev. | Sell | 6,324 | Common Stock | $15.23 | $96,314.52 | 0.63 [ Average ] | 612,866 | $9,333,949.18 | 61.21 [High] | Form 4 | - | 2021-08-05 | Craig E Hunsaker | EVP, People/Culture & GC | Sell | 9,760 | Common Stock | $15.23 | $148,644.80 | 0.97 [ High ] | 1,042,109 | $15,871,320.07 | 104.09 [Very High] | Form 4 | - | 2021-08-05 | David Sponsel | EVP, Sales | Sell | 620 | Common Stock | $15.23 | $9,442.60 | 0.06 [ Very Low ] | 550,598 | $8,385,607.54 | 55.00 [High] | Form 4 | - | 2021-08-09 | Jennifer N. Pritzker | - | Buy | 1,000 | Common Stock | $14.68 | -$14,680.00 | 0.10 [ Low ] | 37,200 | $546,096.00 | 3.72 [Low] | Form 4 | - | 2021-08-09 | Jennifer N. Pritzker | - | Buy | 3,000 | Common Stock | $14.69 | -$44,070.00 | 0.30 [ Average ] | 2,725,805 | $40,042,075.45 | 272.26 [Very High] | Form 4 | See footnote | 2021-08-11 | Jennifer N. Pritzker | - | Buy | 1,000 | Common Stock | $13.13 | -$13,130.00 | 0.10 [ Low ] | 38,200 | $501,566.00 | 3.82 [Low] | Form 4 | - | 2021-08-12 | Elizabeth Ann Altman | - | Buy | 8,870 | Common Stock | $0.00 | $0.00 | - | 8,870 | $0.00 | 0.89 [Very Low] | Form 4 | - | 2021-08-12 | Elizabeth Ann Altman | - | Buy | 21,024 | Common Stock | $0.00 | $0.00 | - | 29,894 | $0.00 | 2.99 [Low] | Form 4 | - | 2021-08-13 | Jennifer N. Pritzker | - | Buy | 1,077 | Common Stock | $12.99 | -$13,990.23 | 0.11 [ Low ] | 1,077 | $13,990.23 | 0.11 [Very Low] | Form 4 | See footnote | 2021-08-17 | Jennifer N. Pritzker | - | Buy | 554 | Common Stock | $12.62 | -$6,991.48 | 0.06 [ Very Low ] | 1,631 | $20,583.22 | 0.16 [Very Low] | Form 4 | See footnote | 2021-08-27 | Jennifer N. Pritzker | - | Buy | 1,000 | Common Stock | $13.26 | -$13,260.00 | 0.10 [ Low ] | 2,000 | $26,520.00 | 0.20 [Very Low] | Form 4 | See footnote | 2021-11-08 | David R Pelizzon | - | Buy | 5,425 | Common Stock | $13.00 | -$70,525.00 | - | 284,483 | $3,698,279.00 | - | Form 4 | - | 2021-11-11 | Patrick Miles | CEO | Buy | 50,000 | Common Stock | $11.71 | -$585,500.00 | 5.04 [ Very High ] | 5,103,837 | $59,765,931.27 | 514.02 [Very High] | Form 4 | - | 2021-11-11 | David R Pelizzon | - | Buy | 4,366 | Common Stock | $11.41 | -$49,816.06 | 0.44 [ Average ] | 288,849 | $3,295,767.09 | 29.09 [High] | Form 4 | - | 2021-11-12 | Craig E Hunsaker | EVP, People/Culture & GC | Buy | 15,000 | Common Stock | $11.66 | -$174,900.00 | 1.51 [ High ] | 1,057,109 | $12,325,890.94 | 106.46 [Very High] | Form 4 | - | 2021-11-10 | Scott Lish | SVP, Development | Sell | 6,250 | Common Stock | $11.79 | $73,687.50 | 0.63 [ Average ] | 265,110 | $3,125,646.90 | 26.70 [High] | Form 4 | - | 2021-11-12 | David Sponsel | EVP, Sales | Sell | 9,847 | Common Stock | $11.56 | $113,831.32 | 0.99 [ High ] | 541,765 | $6,262,803.40 | 54.56 [High] | Form 4 | - | 2021-11-16 | David H Mowry | - | Sell | 14,254 | Common Stock | $12.25 | $174,611.50 | 1.44 [ High ] | 77,797 | $953,013.25 | 7.84 [Average] | Form 4 | - | 2021-11-23 | Jason Hochberg | - | Buy | 5,000 | Common Stock | $10.83 | -$54,150.00 | 0.50 [ Average ] | 79,375 | $859,631.25 | 7.99 [Average] | Form 4 | - | 2021-11-23 | Paul Segal | - | Buy | 67,496 | Common Stock | $10.09 | -$681,034.64 | 6.80 [ Very High ] | 67,496 | $681,034.64 | 6.80 [Average] | Form 4 | - | 2021-11-24 | Paul Segal | - | Buy | 100,000 | Common Stock | $11.17 | -$1,117,000.00 | 10.07 [ Very High ] | 167,496 | $1,870,930.32 | 16.87 [High] | Form 4 | - | 2021-11-26 | Evan Bakst | - | Buy | 10,000 | Common Stock | $10.57 | -$105,700.00 | 1.01 [ High ] | 786,361 | $8,311,835.77 | 79.20 [Very High] | Form 4 | - |
